🇺🇸 Stepwise therapy for dyslipidemia, hypertension and diabetes in United States

Stepwise therapy for dyslipidemia, hypertension and diabetes (Stepwise therapy for dyslipidemia, hypertension and diabetes) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Stepwise therapy for dyslipidemia, hypertension and diabetes in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Stepwise therapy for dyslipidemia, hypertension and diabetes approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Stepwise therapy for dyslipidemia, hypertension and diabetes in United States?

Hospital de Sabadell is the originator. The local marketing authorisation holder may differ — check the official source linked above.